Why the study?
Does intra-articular gene transfer of hIL-10, vIL-10, or mut.hIL-10 improve disease pathology in a rabbit model of antigen-induced arthritis?
Does intra-articular gene transfer of hIL-10, vIL-10, or mut.hIL-10 improve disease pathology in a rabbit model of antigen-induced arthritis?
Local adenovirus-mediated gene transfer of human, viral, or mutant human IL-10 are equally effective in ameliorating disease pathology in a rabbit model of antigen-induced arthritis.
Answers are grounded in this paper and cite their sources.
May guide preclinical IL-10 gene therapy development; leaves open translation to human arthritis.
IL-10 is a Th2 cytokine important for inhibiting cell-mediated immunity while promoting humoral responses. Human IL-10 (hIL-10) has anti-inflammatory, immunosuppressive as well as immunostimulatory characteristics, whereas viral IL-10 (vIL-10), a homologue of hIL-10 encoded by Epstein Barr virus (EBV), lacks several immunostimulatory functions. The immunostimulatory characteristic of hIL-10 has been attributed to a single amino acid, isoleucine at position 87, which in vIL-10 is alanine. A mutant hIL-10 in which isoleucine has been substituted (mut.hIL-10) is biologically active with only immunosuppressive, but not immunostimulatory, functions, making it a potentially superior therapeutic for inflammatory diseases. To compare the efficacy of mut.hIL-10 with hIL-10 and vIL-10 in blocking the progression of rheumatoid arthritis, we used replication defective adenoviral vectors to deliver intra-articularly the gene encoding hIL-10, vIL-10 or mut.hIL-10 to antigen-induced arthritic (AIA) knee joints in rabbits. Intra-articular expression of hIL-10, vIL-10, and mut.hIL-10 resulted in significant improvement of the pathology in the treated joints to similar levels. These observed changes included a significant reduction in intra-articular leukocytosis and the degree of synovitis, as well as normalization of cartilage matrix metabolism. Our results suggest that hIL-10, vIL-10, and mut.hIL-10 are all equally therapeutic in the rabbit AIA model for treating disease pathology.
No takes yet. Share an insight, caveat, or question.
Keravala et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: